![Ralph Smalling](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 203 509 $ in data 30/06/2026
Ralph Smalling is currently an Outside Director at SymBio Pharmaceuticals Ltd. and Vice President & Head-Regulatory Affairs at Genelux Corp.
since 2023.
The education history includes graduate studies at The California State University and undergraduate studies at Occidental College.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
GENELUX CORP. 0,15% | 03/06/2026 | 67.611 ( 0,15% ) | 203 509 $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| GENELUX CORPORATION | Consigliere Generale | 20/07/2023 |
| SYMBIO PHARMACEUTICALS LIMITED | Direttore/Membro del Consiglio | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 4 |
|---|---|
Genelux Corp.
 Genelux Corp. Pharmaceuticals: MajorHealth Technology Manufactures and markets drugs and virus strains solutions | Health Technology |
The California State University
 The California State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Occidental College
 Occidental College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SymBio Pharmaceuticals Ltd.
 SymBio Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapeutics for cancer and other related diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
